US5643944AExpiredUtility
Ovulation control by regulating nitric oxide levels
Est. expiryDec 10, 2013(expired)· nominal 20-yr term from priority
A61K 31/21A61K 31/195A61K 45/06A61K 31/295A61K 31/223A61K 31/26A61K 31/00A61K 31/22A61K 31/198A61K 31/34
69
PatentIndex Score
25
Cited by
12
References
3
Claims
Abstract
The stimulation of ovulation in a female may be achieved by administering a nitric oxide source, optionally in further combination with one or more of clomiphene, a gonadotropin, and an LH-RH agonist.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A method for inducing ovulation comprising administering L-arginine, sodium nitroprusside, nitroglycerin, isosorbide mononitrate or isosorbide dinitrate to a female in an amount stimulating ovulation.
2. A method for stimulating ovulation comprising: administering 10-100 mg of isosorbide mononitrate or isosorbide dinitrate to a female.
3. A method for stimulating ovulation comprising: administering an inducer of nitric oxide production selected from the group consisting of L-arginine, sodium nitroprusside, nitroglycerin, isosorbide mononitrate and isosorbide dinitrate; and administering a therapeutically effective amount of leuprolide acetate, wherein the therapeutically effective amount is about 1-10 mg/day.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.